Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

243 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Choroidal Vascular Changes in Multiple Evanescent White Dot Syndrome.
Pellegrini M, Veronese C, Bernabei F, Lupidi M, Cerquaglia A, Invernizzi A, Zicarelli F, Cimino L, Bolletta E, Vagge A, Ciardella AP. Pellegrini M, et al. Among authors: invernizzi a. Ocul Immunol Inflamm. 2021 Feb 17;29(2):340-345. doi: 10.1080/09273948.2019.1678650. Epub 2019 Nov 7. Ocul Immunol Inflamm. 2021. PMID: 31697565
Clinical Relevance of Subcentimetric Lymph Node Biopsy in the Diagnosis of Ocular Sarcoidosis.
Bolletta E, Mastrofilippo V, Invernizzi A, Aldigeri R, Spaggiari L, Besutti G, Borrelli R, Lococo F, Ricchetti T, Rapicetta C, Cavazza A, Musci G, De Simone L, Gozzi F, Salvarani C, Pipitone N, Paci M, Cimino L. Bolletta E, et al. Among authors: invernizzi a. Ocul Immunol Inflamm. 2022 Apr 3;30(3):717-720. doi: 10.1080/09273948.2020.1817503. Epub 2020 Oct 5. Ocul Immunol Inflamm. 2022. PMID: 33016855
Effectiveness of Infliximab and Interferon Alpha-2a for the Treatment of Behçet's Uveitis: Customizing Therapy according to the Clinical Features.
De Simone L, Invernizzi A, Aldigeri R, Mastrofilippo V, Marvisi C, Gozzi F, Bolletta E, Adani C, Pipitone N, Muratore F, Fontana L, Salvarani C, Cimino L. De Simone L, et al. Among authors: invernizzi a. Ocul Immunol Inflamm. 2022 Feb 17;30(2):506-514. doi: 10.1080/09273948.2020.1815797. Epub 2020 Oct 6. Ocul Immunol Inflamm. 2022. PMID: 33021421
Efficacy of Rituximab Treatment in Vogt-Koyanagi-Harada Disease Poorly Controlled by Traditional Immunosuppressive Treatment.
Bolletta E, Gozzi F, Mastrofilippo V, Pipitone N, De Simone L, Croci S, Invernizzi A, Adani C, Iannetta D, Coassin M, Fontana L, Salvarani C, Cimino L. Bolletta E, et al. Among authors: invernizzi a. Ocul Immunol Inflamm. 2022 Aug;30(6):1303-1308. doi: 10.1080/09273948.2021.1880604. Epub 2021 Apr 1. Ocul Immunol Inflamm. 2022. PMID: 33793383
243 results